Stamos Capital Partners, L.P.
Source: SEC Form 13F · as of Mar 2026Stamos Capital Partners, L.P. holds 11 biotech & pharma companies tracked by BioSniper, totaling $76.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$76.1M
| Company | Shares | Value |
|---|---|---|
| MRKMerck & Co., Inc. | 170,384 | $20.5M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 54,597 | $14.8M |
| JNJJOHNSON & JOHNSON | 41,659 | $10.2M |
| PFEPFIZER INC | 273,784 | $7.7M |
| NVONovo Nordisk A/S | 177,423 | $6.5M |
| LLYELI LILLY & Co | 6,129 | $5.6M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 98,255 | $5.4M |
| GMOptec International, Inc. | 28,516 | $2.1M |
| IQVIQVIA Holdings Inc. | 10,452 | $1.8M |
| GILDGILEAD SCIENCES, INC. | 5,788 | $807K |
| AMGNAMGEN INC | 1,930 | $679K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.